Khouri Highlights the Ongoing AFFIRM-AL Trial in AL Amyloidosis
Season 9, Episode 40, Nov 09, 2023, 08:15 PM
Dr Khouri discusses unmet needs in AL amyloidosis, the potential for birtamimab to become a new frontline standard of care beyond daratumumab, and the importance of confirming earlier post-hoc results from the placebo-controlled phase 3 VITAL trial in the ongoing AFFIRM-AL trial in patients with Mayo stage IV AL amyloidosis with cardiac involvement.